Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Jones

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
The Clinical Biochemist. Reviews|February 2, 2006
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statementNagesh Anavekar, Renze Bais, Shane Carney, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2026
Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapyEman Wehbe, Thulashigan Sreeharan, Gaurav Sutrave, et al.
Peerj|February 21, 2019
Embracing heterogeneity: coalescing the Tree of Life and the future of phylogenomicsGustavo A Bravo, Alexandre Antonelli, Christine D Bacon, et al.
Journal of Critical Care|November 29, 2005
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot studyDeborah J Cook, Graeme Rocker, Maureen Meade, et al.
International Journal of Epidemiology|May 26, 2018
Cohort profile: The Childhood Asthma Prevention Study (CAPS)Frances L Garden, Brett G Toelle, Seema Mihrshahi, et al.
BMJ Open|February 17, 2018
Delivering safe and effective test-result communication, management and follow-up: a mixed-methods study protocolMaria R Dahm, Andrew Georgiou, Johanna I Westbrook, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2011
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerasesTimothy J Miles, Jeffrey M Axten, Christopher Barfoot, et al.
Plos Computational Biology|April 9, 2019
BEAST 2.5: An advanced software platform for Bayesian evolutionary analysisRemco Bouckaert, Timothy G Vaughan, Joëlle Barido-Sottani, et al.
Journal of Medicinal Chemistry|March 30, 2021
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's DiseaseAmanda Van de Poël, Leticia Toledo-Sherman, Perla Breccia, et al.
Journal of Medicinal Chemistry|January 8, 2016
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)Timothy P Heffron, Robert A Heald, Chudi Ndubaku, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
The Clinical Biochemist. Reviews|February 2, 2006
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statementNagesh Anavekar, Renze Bais, Shane Carney, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2026
Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapyEman Wehbe, Thulashigan Sreeharan, Gaurav Sutrave, et al.
Peerj|February 21, 2019
Embracing heterogeneity: coalescing the Tree of Life and the future of phylogenomicsGustavo A Bravo, Alexandre Antonelli, Christine D Bacon, et al.
Journal of Critical Care|November 29, 2005
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot studyDeborah J Cook, Graeme Rocker, Maureen Meade, et al.
International Journal of Epidemiology|May 26, 2018
Cohort profile: The Childhood Asthma Prevention Study (CAPS)Frances L Garden, Brett G Toelle, Seema Mihrshahi, et al.
BMJ Open|February 17, 2018
Delivering safe and effective test-result communication, management and follow-up: a mixed-methods study protocolMaria R Dahm, Andrew Georgiou, Johanna I Westbrook, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2011
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerasesTimothy J Miles, Jeffrey M Axten, Christopher Barfoot, et al.
Plos Computational Biology|April 9, 2019
BEAST 2.5: An advanced software platform for Bayesian evolutionary analysisRemco Bouckaert, Timothy G Vaughan, Joëlle Barido-Sottani, et al.
Journal of Medicinal Chemistry|March 30, 2021
Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's DiseaseAmanda Van de Poël, Leticia Toledo-Sherman, Perla Breccia, et al.
Journal of Medicinal Chemistry|January 8, 2016
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)Timothy P Heffron, Robert A Heald, Chudi Ndubaku, et al.
Pageof 13